ArticleThe Journal of experimental medicine2014

Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapy.

Elisa Oricchio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.